YCY
NYSE · N/A
Aa Mission Acquisition-A
$10.20
+0.02 (+0.20%)
Open$10.19
Previous Close$10.18
Day High$10.20
Day Low$10.19
52W High$10.20
52W Low$9.90
Volume—
Avg Volume57.0K
Market Cap121.33M
P/E Ratio464.73
EPS$0.00
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 39.01M | 40.32M | 32.67M |
| Net Income | 1.80M | 2.30M | 1.57M |
| Profit Margin | 4.6% | 5.7% | 4.8% |
| EBITDA | 3.33M | 3.18M | 2.52M |
| Free Cash Flow | 1.88M | 2.00M | 1.33M |
| Rev Growth | +9.1% | -6.2% | +4.8% |
| Debt/Equity | 0.57 | 0.61 | 0.48 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.33 | +0.96% | — | 3.76B |
| PICS | Pics Nv | $11.07 | -1.51% | 6.4 | 1.43B |
| DMII | Drugs Made In America Acquis | $10.09 | +0.20% | 74.9 | 642.73M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.70 | +0.28% | 35.3 | 335.10M |
| CEPF | Cantor Equity Partners-Cl A | $10.40 | -0.10% | 57.7 | 594.36M |